Liver disease (hepatitis, cirrhosis) — all decisions

The Board remands the claims for service connection for heart disease and liver disability, to include supraventricular arrhythmia and cirrhosis respectively, due to water contamination at Camp Lejeune.

The Board granted service connection for hepatic cirrhosis as secondary to the Veteran's service-connected hepatitis C.

The Board denied the Veteran's claims for an initial compensable rating for hearing loss and chronic lymphocytic leukemia (CLL) and remanded service connection claims for dizziness as secondary to hearing loss and liver cirrhosis.

The Board remands the claim for service connection for hepatitis, including as secondary to service-connected foot conditions, for an adequate VA medical examination.

The Board granted service connection for hepatitis C and liver cancer, but remanded the claim for diabetes mellitus due to further evidence needed.

The Board denied service connection for liver disabilities other than hepatitis C, finding that the evidence did not support a causal relationship between the Veteran's current liver conditions and his active military service.

The Board denied service connection for all claimed conditions as the evidence of record does not support a finding that any diagnosed condition is related to the Veteran's active duty service or to a service-connected disability.

The Board denied service connection for rectal cancer, autoimmune hepatitis with liver cirrhosis, and emphysema as there is no evidence linking these conditions to the Veteran's military service.

The Board granted service connection for liver disease, diagnosed as nonalcoholic steatohepatitis (NASH), metabolic dysfunction-associated steatohepatitis liver disease (MASLD), and cirrhosis of the liver, based on a nexus to in-service herbicide exposure.

The Board granted an effective date of March 8, 2023 for the award of service connection for plantar fasciitis. The claims for angina pectoris, kidney disability, liver disability, and skin cancer were remanded.

The Board denied service connection for cirrhosis of the liver as it was not shown to be related to the Veteran's active service or a service-connected disability, including due to alcohol use disorder.

The Board remands the issue of entitlement to a disability rating in excess of 10 percent for cirrhosis due to a need for further development and an opinion regarding the severity of the Veteran's liver cirrhosis from February 2002 to June 2020.

The Board denied service connection for autoimmune hepatitis, rheumatoid arthritis, a gastrointestinal disorder, an acquired psychiatric disorder, and an internal bleeding disorder as there was no evidence of current disabilities or functional impairments related to these conditions.

The Veteran's service-connected disabilities prevented him from obtaining and maintaining substantially gainful employment prior to April 29, 2021.

The Board granted a 10 percent evaluation for service-connected bilateral posterior chamber intraocular lenses, status post cataract surgery and denied an initial compensable evaluation for service-connected bilateral dry eye syndrome. The claim for service connection for a liver disorder was also denied.

The Board granted service connection for chronic kidney disease, which is related to the Veteran's service-connected hypertension. The other claims were remanded for further development.

The Board remands the claims for service connection for an acquired psychiatric disorder and hepatitis C to obtain additional evidence, including a VA examination.

The Board granted eligibility for direct payment of attorney fees from past due benefits awarded in the portion of a November 2023 rating decision granting higher ratings for Hepatitis B residuals as well as gout symptomatology of the left and right great toes, but denied such eligibility for service connection of allergic rhinitis.

The Board grants service connection for hepatitis C, finding that the Veteran's high-risk sexual activity in service likely resulted in his development of the condition.

The Board remands the claim for a new medical opinion to address the nature and etiology of the Veteran's cause of death, specifically regarding its relation to presumed herbicide agent exposure.